Identification of the up-regulation of TP-alpha, collagen alpha-1(VI) chain, and S100A9 in esophageal squamous cell carcinoma by a proteomic method

Journal of Proteomics

Volumn 75, Issue 13, 2012, Pages 3977-3986

  Fan, Nai Jun ^a,b   Gao, Chun Fang ^a   Wang, Chang Song ^a   Zhao, Guang ^a   Lv, Jing Jing ^a   Wang, Xiu Li ^a   Chu, Guang Hui ^a   Yin, Jian ^a   Li, Dong Hui ^a   Chen, Xiao ^a   Yuan, Xu Tao ^a   Meng, Nian Long ^a  

^a No 150 Central Hospital of PLA   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biological markers; Collagen alpha 1(VI) chain; Esophageal neoplasms; Proteomics; S100A9 protein; TP alpha

Indexed keywords

BETA ACTIN; BIOLOGICAL MARKER; CALGRANULIN B; COLLAGEN 6 ALPHA1; PROTEIN TP ALPHA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISOBARIC TAGS FOR RELATIVE AND ABSOLUTE QUANTITATION; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; UPREGULATION; VALIDATION PROCESS; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CALGRANULIN B; CARCINOMA, SQUAMOUS CELL; CHILD; CHILD, PRESCHOOL; COLLAGEN TYPE VI; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIENZYME COMPLEXES; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84862653185     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.05.008     Document Type: Article

References (37)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Tran G.D., Sun X.D., Abnet C.C., Fan J.H., Dawsey S.M., Dong Z.W., et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer 2005, 113:456-463.
3. Gholipour C., Shalchi R.A., Abbasi M. A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003. Dis Esophagus 2008, 21:322-327.
4. Stein H.J., Sendler A., Fink U., Siewert J.R. Multidisciplinary approach to esophageal and gastric cancer. Surg Clin North Am 2000, 80:659-682. discussions 83-6.
5. Zhou S.L., Wang L.D. Circulating microRNAs: novel biomarkers for esophageal cancer. World J Gastroenterol 2010, 16:2348-2354.
6. Bird-Lieberman E.L., Fitzgerald R.C. Early diagnosis of oesophageal cancer. Br J Cancer 2009, 101:1-6.
7. Zhu X., Ding M., Yu M.L., Feng M.X., Tan L.J., Zhao F.K. Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis. BMC Cancer 2010, 10:290.
8. Yang Y.F., Li H., Xu X.Q., Diao Y.T., Fang X.Q., Wang Y., et al. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis. Dis Esophagus 2008, 21:395-401.
9. McHugh S.M., O'Donnell J., Gillen P. Genomic and oncoproteomic advances in detection and treatment of colorectal cancer. World J Surg Oncol 2009, 7:36.
10. Kelly P., Appleyard V., Murray K., Paulin F., Lamont D., Baker L., et al. Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenografts in response to chemotherapy. Br J Cancer 2010, 103:232-238.
11. Yan S., Zhou C., Lou X., Xiao Z., Zhu H., Wang Q., et al. PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma. Cancer Res 2009, 69:3283-3290.
12. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999, 17:994-999.
13. Jin G.Z., Li Y., Cong W.M., Yu H., Dong H., Shu H., et al. iTRAQ-2DLC-ESI-MS/MS based identification of a new set of immunohistochemical biomarkers for classification of dysplastic nodules and small hepatocellular carcinoma. J Proteome Res 2011, 10:3418-3428.
14. Ralhan R., Desouza L.V., Matta A., Chandra Tripathi S., Ghanny S., Datta Gupta S., et al. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry. Mol Cell Proteomics 2008, 7:1162-1173.
15. Schlemper R.J., Riddell R.H., Kato Y., Borchard F., Cooper H.S., Dawsey S.M., et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000, 47:251-255.
16. Jin J., Park J., Kim K., Kang Y., Park S.G., Kim J.H., et al. Detection of differential proteomes of human beta-cells during islet-like differentiation using iTRAQ labeling. J Proteome Res 2009, 8:1393-1403.
17. Guo Y., Singleton P.A., Rowshan A., Gucek M., Cole R.N., Graham D.R., et al. Quantitative proteomics analysis of human endothelial cell membrane rafts: evidence of MARCKS and MRP regulation in the sphingosine 1-phosphate-induced barrier enhancement. Mol Cell Proteomics 2007, 6:689-696.
18. Shilov I.V., Seymour S.L., Patel A.A., Loboda A., Tang W.H., Keating S.P., et al. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics 2007, 6:1638-1655.
19. Lu H., Yang Y., Allister E.M., Wijesekara N., Wheeler M.B. The identification of potential factors associated with the development of type 2 diabetes: a quantitative proteomics approach. Mol Cell Proteomics 2008, 7:1434-1451.
20. Zhang L., Jia X., Feng Y., Peng X., Zhang Z., Zhou W., et al. Plasma membrane proteome analysis of the early effect of alcohol on liver: implications for alcoholic liver disease. Acta Biochim Biophys Sin (Shanghai) 2011, 43:19-29.
21. Arora S., Kaur J., Sharma C., Mathur M., Bahadur S., Shukla N.K., et al. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Clin Cancer Res 2005, 11:2272-2284.
22. Koomen J.M., Haura E.B., Bepler G., Sutphen R., Remily-Wood E.R., Benson K., et al. Proteomic contributions to personalized cancer care. Mol Cell Proteomics 2008, 7:1780-1794.
23. Latterich M., Abramovitz M., Leyland-Jones B. Proteomics: new technologies and clinical applications. Eur J Cancer 2008, 44:2737-2741.
24. Martyniuk C.J., Denslow N.D. Towards functional genomics in fish using quantitative proteomics. Gen Comp Endocrinol 2009, 164:135-141.
25. Peters C.J., Fitzgerald R.C. Systematic review: the application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma. Aliment Pharmacol Ther 2007, 25:1253-1269.
26. Ong C.A., Lao-Sirieix P., Fitzgerald R.C. Biomarkers in Barrett's esophagus and esophageal adenocarcinoma: predictors of progression and prognosis. World J Gastroenterol 2010, 16:5669-5681.
27. Harris J.C., Clarke P.A., Awan A., Jankowski J., Watson S.A. An antiapoptotic role for gastrin and the gastrin/CCK-2 receptor in Barrett's esophagus. Cancer Res 2004, 64:1915-1919.
28. Baldwin G.S. Antiproliferative gastrin/cholecystokinin receptor antagonists target the 78-kDa gastrin-binding protein. Proc Natl Acad Sci U S A 1994, 91:7593-7597.
29. Baldwin G.S., Murphy V.J., Yang Z., Hashimoto T. Binding of nonsteroidal antiinflammatory drugs to the alpha-subunit of the trifunctional protein of long chain fatty acid oxidation. J Pharmacol Exp Ther 1998, 286:1110-1114.
30. Chiu K.H., Chang Y.H., Wu Y.S., Lee S.H., Liao P.C. Quantitative secretome analysis reveals that COL6A1 is a metastasis-associated protein using stacking gel-aided purification combined with iTRAQ labeling. J Proteome Res 2011, 10:1110-1125.
31. Ehrchen J.M., Sunderkotter C., Foell D., Vogl T., Roth J. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol 2009, 86:557-566.
32. Ichikawa M., Williams R., Wang L., Vogl T., Srikrishna G. S100A8/A9 activate key genes and pathways in colon tumor progression. Mol Cancer Res 2011, 9:133-148.
33. Su Y.J., Xu F., Yu J.P., Yue D.S., Ren X.B., Wang C.L. Up-regulation of the expression of S100A8 and S100A9 in lung adenocarcinoma and its correlation with inflammation and other clinical features. Chin Med J (Engl) 2011, 123:2215-2220.
34. Zhu X., Lv J., Yu L., Zhu X., Wu J., Zou S., et al. Proteomic identification of differentially-expressed proteins in squamous cervical cancer. Gynecol Oncol 2009, 112:248-256.
35. Sewell D.A., Yuan C.X., Robertson E. Proteomic signatures in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2007, 69:77-84.
36. Wang J., Cai Y., Xu H., Zhao J., Xu X., Han Y.L., et al. Expression of MRP14 gene is frequently down-regulated in Chinese human esophageal cancer. Cell Res 2004, 14:46-53.
37. Kong J.P., Ding F., Zhou C.N., Wang X.Q., Miao X.P., Wu M., et al. Loss of myeloid-related proteins 8 and myeloid-related proteins 14 expression in human esophageal squamous cell carcinoma correlates with poor differentiation. World J Gastroenterol 2004, 10:1093-1097.